Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
This study is testing a new way to manage fluid removal during hemodialysis (a treatment for kidney failure) called IBPS-Guided Ultrafiltration. The goal is to reduce extra body fluid without causing dangerous drops in blood pressure during dialysis. Researchers will look at your blood pressure patterns during dialysis and use a special plan to decide how much fluid to remove. This study is for people aged 18 and older who are on hemodialysis and have high blood pressure either before or after their dialysis sessions. The main goal is to see if this new approach can improve your systolic blood pressure (the top number in a blood pressure reading) after 4 months.
- Study design
- This is an interventional study planning to enroll 69 participants. It is not specified if it is randomized or blinded.
- What's involved
- Each month, a study investigator will review your average blood pressure patterns from the prior two weeks to adjust fluid removal.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your ambulatory systolic blood pressure will be measured at 4 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Peter Noel Van Buren, MD · PRINCIPAL_INVESTIGATOR · VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Ambulatory Systolic Blood Pressure4 months
Will compare between-group difference in change in ambulatory systolic blood pressure from baseline to 4-month follow up